₩ 61700
Key Takeaways
Risk factor
Modest price volatility
Data is available to registered users only
Data is available to registered users only
Profitability factor
Undervalued vs peers
Data is available to registered users only
Data is available to registered users only
About
Chong Kun Dang Pharmaceutical Corp. engages in the manufacture, distribution, research, and development of pharmaceuticals. Its products include medicine for antidiabetics, antiviruses, beta-blockers, anti-hyperlipidemia, and others. The company was founded on May 7, 1941 and is headquartered in Seoul, South Korea.
Company Valuation
From both historical and forecast perspectives, the stock is underpriced compared to similar stocks. In particular, the stock is underpriced on P/E, of fair value on EV/E
Data is available to registered users only
Target Price
The average target price of 185750.KS is 100379 and suggests 55.4% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation
Data is available to registered users only